6Kahan BD, Rajagopalan PR, Hall M. Reduction of the occurrence of acute celluar rejection among renal allograft recipients treated with basilixmab, a chimeric anti-interleukin-2-monoclonal antibody 1, 2. Transplantation, 1999, 67 (2): 276-284.
7Vincenti F, Lantz M, Birnbaum J, et al. A phase I trial of humanized anti-interleukin 2 receptor antibody (HAT)in renal transplantation. Transplantation, 1997, 63 (1): 33 -38.
8Matas A J, Gillingham K J, Payne WD, et al. The impact of an acute rejection episode on long-term renal allograft survival (t1 / 2). Transplantation, 1994, 57 (6): 857-859.
9Tomasoni S,Remuzzi G,Benigni A.Allograft rejection:Acute and chronic studies[J].Contrib Nephrol,2008,159:122-134.
